Answers are grounded in this paper and cite their sources.
Cross-sectional study demonstrates reduced acute exacerbation risk with three consecutive influenza vaccines in COPD patients, highlighting the clinical benefit of annual immunization.
Background: Influenza (flu) is one of the most frequent infections associated with acute exacerbations of Chronic ObstructivePulmonary Disease (COPD). Objective: To determine the association between flu vaccine use and acute exacerbation ofCOPD and the cost of COPD exacerbations. Methods: Cross-sectional, multicenter study at two hospitals and three clinics inLima and Callao, Peru. All subjects had a COPD diagnosis based on The Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria (e.g., age 3 40 years old, smoker or ex-smoker, spirometry test). Sociodemographic, clinical, and COPD-relatedvariables were collected using questionnaires and medical records. Multivariate analysis using multiple logistic regression wasperformed to measure the association between the use of the flu vaccine and acute exacerbations of COPD. Results: Onehundred twelve patients were included, with a median age of 70 years (interquartile range: 63.5-75.0 years). Of these, 37.5%were vaccinated against flu, and 51.79% had at least one COPD exacerbation. In the adjusted analysis, being vaccinated theprevious year with the flu vaccine was not significatively associated with fewer exacerbations (OR=0.49, 95% CI 0.15-1.57;p=0.230), whereas being vaccinated three consecutive previous years was associated with significative fewer exacerbations(OR=0.13, 95% CI 0.02-0.91; p=0.040). The mean cost of an inpatient COPD exacerbation was USD 7,150.70. Conclusions:This study did not show a statistically significant relationship between having flu vaccination the previous year and fewerCOPD exacerbations in Peruvian patients, which was the primary study objective; however, this shows a statistically significantrelationship between the use of three consecutive flu vaccines and fewer exacerbations.
No takes yet. Share an insight, caveat, or question.
Torres‐Zevallos et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: